These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31099891)

  • 21. Item-specific patterns of the Skindex-17 in individuals with different levels of Hidradenitis Suppurativa severity: a network analysis study.
    Raimondi G; Samela T; Fania L; Abeni D
    Front Public Health; 2023; 11():1284365. PubMed ID: 38026379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of Life in Cohabitants of Patients with Hidradenitis Suppurativa: A Cross-sectional Study.
    Ramos-Alejos-Pita C; Arias-Santiago S; Molina-Leyva A
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32824800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gynecological aspects of hidradenitis suppurativa].
    Kiss N; Plázár D; Lőrincz K; Bánvölgyi A; Valent S; Wikonkál N
    Orv Hetil; 2019 Feb; 160(8):291-299. PubMed ID: 30773037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a Quality-of-Life Measure for Hidradenitis Suppurativa.
    Sisic M; Kirby JS; Boyal S; Plant L; McLellan C; Tan J
    J Cutan Med Surg; 2017; 21(2):152-155. PubMed ID: 27837158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The psychosocial impact of hidradenitis suppurativa.
    Gooderham M; Papp K
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S19-22. PubMed ID: 26470609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Handicap of Hidradenitis Suppurativa.
    Deckers IE; Kimball AB
    Dermatol Clin; 2016 Jan; 34(1):17-22. PubMed ID: 26617353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression in patients with hidradenitis suppurativa.
    Onderdijk AJ; van der Zee HH; Esmann S; Lophaven S; Dufour DN; Jemec GB; Boer J
    J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):473-8. PubMed ID: 22339940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes.
    Kimball AB; Kirby J; Ingram JR; Tran T; Pansar I; Ciaravino V; Willems D; Lewis-Mikhael AM; Tongbram V; Garg A
    Dermatol Ther (Heidelb); 2024 Jan; 14(1):83-98. PubMed ID: 38183616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
    Chernyshov PV; Zouboulis CC; Tomas-Aragones L; Jemec GB; Svensson A; Manolache L; Tzellos T; Sampogna F; Pustisek N; van der Zee HH; Marron SE; Spillekom-van Koulil S; Bewley A; Linder D; Abeni D; Szepietowski JC; Augustin M; Finlay AY
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1633-1643. PubMed ID: 31037773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anger, Emotional Fragility, Self-esteem, and Psychiatric Comorbidity in Patients with Hidradenitis Suppurativa/Acne Inversa.
    Tugnoli S; Agnoli C; Silvestri A; Giari S; Bettoli V; Caracciolo S
    J Clin Psychol Med Settings; 2020 Sep; 27(3):527-540. PubMed ID: 31222671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease severity and poor mental health are the main predictors of stigmatization in patients with hidradenitis suppurativa.
    Akoglu G; Yildiz I; Karaismailoğlu E; Esme P
    Dermatol Ther; 2021 May; 34(3):e14910. PubMed ID: 33619860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pain and late-onset of hidradenitis suppurativa can have a negative influence on occupational status and educational level. A cross-sectional study.
    Barboza-Guadagnini L; Podlipnik S; Fuertes I; Morgado-Carrasco D; Bassas-Vila J
    Actas Dermosifiliogr; 2023 Jan; 114(1):T1-T8. PubMed ID: 36503621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of high expectations of self and social desirability in emotional processing in individuals with irritable bowel syndrome: A qualitative study.
    Sibelli A; Chalder T; Everitt H; Workman P; Bishop FL; Moss-Morris R
    Br J Health Psychol; 2017 Nov; 22(4):737-762. PubMed ID: 28862389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standing up together to the shame and stigma associated with hidradenitis suppurativa.
    Kirby JS; Leiphart P
    Br J Dermatol; 2020 Feb; 182(2):267-268. PubMed ID: 31789426
    [No Abstract]   [Full Text] [Related]  

  • 36. Association of Hidradenitis Suppurativa With Body Image.
    Schneider-Burrus S; Jost A; Peters EMJ; Witte-Haendel E; Sterry W; Sabat R
    JAMA Dermatol; 2018 Apr; 154(4):447-451. PubMed ID: 29466546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alexithymia affects patients with hidradenitis suppurativa.
    Chiricozzi A; Giovanardi G; Caro DRC; Iannone M; Garcovich S; Dini V; De Simone C; Franceschini C; Oranges T; Mingrone G; Capristo E; Di Raimondo C; Bianchi L; Peris K
    Eur J Dermatol; 2018 Aug; 28(4):482-487. PubMed ID: 30325328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uncovering burden disparity: A comparative analysis of the impact of moderate-to-severe psoriasis and hidradenitis suppurativa.
    Hamzavi IH; Sundaram M; Nicholson C; Zivkovic M; Parks-Miller A; Lee J; Yi J; Gu Y; Okun MM; Ganguli A; Arikian SR
    J Am Acad Dermatol; 2017 Dec; 77(6):1038-1046. PubMed ID: 28917381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-specific physical and mental health status in Italian patients with hidradenitis suppurativa: a comparison with the general population.
    Sampogna F; Fania L; Mastroeni S; Ciccone D; Panebianco A; Abeni D
    Arch Dermatol Res; 2021 Jan; 313(1):41-47. PubMed ID: 32270321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
    Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
    Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.